DKSC - Dakshidin Corporation, Inc.
Other OTC - Other OTC Delayed Price. Currency in USD
At close: 10:58AM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 0.0006 |
| Open | 0.0004 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0006 - 0.0006 |
| 52 Week Range | 0.0004 - 0.0019 |
| Volume | |
| Avg. Volume | 1,762,968 |
| Market Cap | 43,749 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Newsfile
Dakshidin Corporation (DKSC), Signs an Exclusive Distribution Deal with Stenergy LLC
San Francisco, California--(Newsfile Corp. - October 13, 2022) - Dakshidin Corporation (OTC Pink: DKSC) has signed a distribution deal with one of the market's most exciting manufacturers of all-natural organic supplements.STENERGY LLC offers a product named GluCora™. Stenergy co-founder Sam Butero describes GluCora; "Health Canada has approved GluCora. As a result, we are bringing a product to the market that supports healthy glucose metabolism. In addition, we provide antioxidants for the main